June 2026
Proprietary AI analyst is now available
Largest Medical Imaging & Diagnostics Public Companies in South Korea
Benchmark revenue and EBITDA valuation multiples for public comps like
Lunit, Bioneer, Infinitt Healthcare, Vuno and Deepnoid.
 | Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression. | $10 | -74% | $741M | $811M | 14.8x | (114.7x) | ||
| Bioneer Corp engages in the manufacture and sale of biotechnological products in South Korea. It offers deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits, DNA and ribonucleic acid (RNA) amplification products, human diagnostics kits, veterinary diagnostics kits, among others. | $5 | -44% | $140M | $149M | 0.7x | 9.7x | ||
| Infinitt Healthcare Co Ltd is a Korea-based company engaged in developing digital solutions used in hospitals. The company offers clinical solutions, enterprise imaging solutions and radiology solutions. The solutions offered by the company are enterprise imaging, radiology, cardiology, pathology, dental imaging, and other cloud solutions. | $5 | +4% | $114M | ($10M) | (0.2x) | (0.4x) | ||
| Vuno Inc is engaged in the business of manufacturing medical devices and equipment. The company develops and markets bone age testing equipment, brain quantification medical device, X-ray reading aid solutions, imaging devices, and other related devices. | $5 | -62% | $77M | $58M | 2.5x | (23.9x) | ||
| Deepnoid Inc is a doctor-driven medical AI platform. It is an open platform that supports doctor-led medical imaging AI model research efficiently. It uses both the image processing module and neural network module provided by default for free, and can effectively use computing resources in the form of a cloud. | $2 | -59% | $39M | $31M | 6.4x | (5.0x) | ||
| Median | $5 | -59% | $114M | $58M | 2.5x | (5.0x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.